Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes.

Ammirati E, Vermi AC, Cianflone D, Banfi M, Foglieni C, Godino C, Airoldi F, Ferri LA, Gorman CL, Manfredi AA, Maseri A, Cope AP, Monaco C.

Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2305-11. doi: 10.1161/ATVBAHA.108.174144. Epub 2008 Sep 11.

2.

Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes.

Zal B, Kaski JC, Arno G, Akiyu JP, Xu Q, Cole D, Whelan M, Russell N, Madrigal JA, Dodi IA, Baboonian C.

Circulation. 2004 Mar 16;109(10):1230-5. Epub 2004 Mar 1.

3.

Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus.

Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, Montone RA, Pazzano V, Pedicino D, Biasucci LM, Ghirlanda G, Crea F.

Eur Heart J. 2011 May;32(10):1214-26. doi: 10.1093/eurheartj/ehq499. Epub 2011 Jan 8.

PMID:
21217142
4.

High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.

Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, Bunce N, Kaski JC.

Circ Res. 2012 Mar 16;110(6):857-69. doi: 10.1161/CIRCRESAHA.111.261933. Epub 2012 Jan 26.

5.

Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events.

Liuzzo G, Biasucci LM, Trotta G, Brugaletta S, Pinnelli M, Digianuario G, Rizzello V, Rebuzzi AG, Rumi C, Maseri A, Crea F.

J Am Coll Cardiol. 2007 Oct 9;50(15):1450-8. Epub 2007 Sep 24.

6.

[Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].

Musiał K, Ciszak L, Kosmaczewska A, Szteblich A, Pawlak E, Zwolińska D, Frydecka I.

Przegl Lek. 2006;63 Suppl 3:208-10. Polish.

PMID:
16898532
7.

Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells.

Tonutti E, Sala P, Feruglio C, Yin Z, Colombatti A.

Clin Immunol Immunopathol. 1994 Dec;73(3):312-20.

PMID:
7955559
8.

Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome.

Backteman K, Andersson C, Dahlin LG, Ernerudh J, Jonasson L.

PLoS One. 2012;7(3):e32691. doi: 10.1371/journal.pone.0032691. Epub 2012 Mar 1.

9.

T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM.

Circulation. 2002 Feb 5;105(5):570-5.

10.

Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.

Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M.

Br J Haematol. 2000 Dec;111(3):817-25.

PMID:
11122143
11.

Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine.

Liu CP, Ueda R, She J, Sancho J, Wang B, Weddell G, Loring J, Kurahara C, Dudley EC, Hayday A, et al.

EMBO J. 1993 Dec;12(12):4863-75.

12.

Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease.

Frydecka I, Kaczmarek P, Boćko D, Kosmaczewska A, Morilla R, Catovsky D.

Leuk Lymphoma. 1999 Nov;35(5-6):545-54.

PMID:
10609792
13.

Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.

Eleftheriadis T, Kartsios C, Yiannaki E, Antoniadi G, Kazila P, Pliakos K, Liakopoulos V, Markala D.

Nephrology (Carlton). 2009 Aug;14(5):471-5. doi: 10.1111/j.1440-1797.2008.01041.x. Epub 2009 Mar 26.

PMID:
19486472
14.

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

Kay N, Leong T, Kyle RA, Greipp P, Van Ness B, Bone N, Oken MM.

Leuk Lymphoma. 1999 Mar;33(1-2):127-33.

PMID:
10194129
15.

Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients.

Eleftheriadis T, Kartsios C, Yiannaki E, Kazila P, Antoniadi G, Liakopoulos V, Markala D.

Am J Nephrol. 2008;28(1):152-7. Epub 2007 Oct 19.

PMID:
17951997
16.

Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer.

Healy CG, Simons JW, Carducci MA, DeWeese TL, Bartkowski M, Tong KP, Bolton WE.

Cytometry. 1998 Jun 1;32(2):109-19.

PMID:
9627224
17.

The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.

Frydecka I, Boćko D, Kosmaczewska A, Ciszak L, Morilla R.

Br J Cancer. 2001 May 18;84(10):1339-43.

18.

Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease.

Zal B, Kaski JC, Akiyu JP, Cole D, Arno G, Poloniecki J, Madrigal A, Dodi A, Baboonian C.

J Immunol. 2008 Oct 15;181(8):5233-41.

19.

Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.

Téo FH, de Oliveira RT, Mamoni RL, Ferreira MC, Nadruz W Jr, Coelho OR, Fernandes Jde L, Blotta MH.

Cell Immunol. 2013 Jan;281(1):11-9. doi: 10.1016/j.cellimm.2013.01.007. Epub 2013 Jan 29.

PMID:
23416719
20.

Supplemental Content

Support Center